1 INDICATIONS AND USAGE Aripiprazole oral tablets are indicated for the treatment of: • Schizophrenia [see Clinical Studies ( 14.1 )] Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc.’s ABILIFY ® (aripiprazole) product. However, due to Otsuka America Pharmaceutical, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information. Aripiprazole tablets are an atypical antipsychotic. The oral formulations are indicated for: • Schizophrenia ( 14.1 )